Clinical Trial Update: Acetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer Undergoing Chemotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial of Acetyl-L-Carnitine hydrochloride to prevent chemotherapy-induced peripheral neuropathy in patients with recurrent ovarian cancer, primary per…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Acetyl-L-Carnitine hydrochloride (Acetyl-L-Carnitine hydrochloride)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Fatigue, Malignant Ovarian Mixed Epithelial Tumor | Phase 3 | Status: WITHDRAWN